Tempus is a tech company focused on collecting huge volumes of molecular clinical data and analyzing them. Tempus was co-founded by Eric Lefkofsky and Brad Keywell in 2016 with the intention of advancing precision medicine and modernizing cancer treatment. It has since developed systems capable of gathering and analyzing data at scale.
Tempus is currently working with patients suffering from breast, lung and pancreatic cancer. It has collaborated with various hospitals such as the Cleveland Clinic, Penn’s Abramson Cancer Center, Duke University School of Medicine and community hospitals around the country. On September 2017, Tempus was valued at $700 million.
Accelerated Disruption refers to when a business grows at a speed that is relative to the next tech advancement. Businesses that have mastered the power of technology and can control its forces will be more competitive in the future. Accelerated disruption deals with choosing the right industry to innovate. Eric Lefkofsky is an entrepreneur who helped create different technology startups worth a billion dollars in Chicago. This explains how disruptive businesses are formed, grown and sustained to make your ideas a reality.
Eric Lefkofsky came into this world on September 2, 1969. He attended Tamarack camps and later worked as a staff member. He studied at Southfield –Lathrup High School before attending the University of Michigan in 1991, where he graduated with honors. He then received his Juris doctor at the University of Michigan Law School.
After school, Eric combined efforts with a friend and bought a clothing company using money borrowed from friends and relatives. They later created an internet company that specialized in promotion of products. The firm experienced rapid growth and was later sold in 2000. Lefkofsky has had a number of entrepreneurial ventures and the current one is Tempus, which he co-founded in 2016. Tempus is a cancer treatment technology company where physicians deliver personalized care.
Lefkofsky has a great interest in the community and was on the board of directors at Children’s Memorial Hospital in Chicago, a trustee of Steppenwolf Theatre Company, and on the board of directors at the Museum of Science and industry. He also served as the co-chairman of the world business Chicago technology council.
To Know More Click Here